Dr. Green's expertise includes regulation of gene transcription and lipid metabolism in the context of metabolic disease and cancer. His expertise focuses on understanding how Western diet-induced changes in metabolism, particularly sphingolipids, contribute to the development of obesity-related metabolic disease and cancer.

My laboratory will focus on understanding liver metabolism in normal and diseased states. Our goal is to investigate how bile acids and nuclear receptors maintain metabolic homeostasis and contribute to liver diseases, including cancer, using cell-based systems and genetically engineered mouse models.<br><br>

Dr. Jessica Hartman is a tenure-track Assistant Professor in the Department of Biochemistry and Molecular Biology and the Department of Regenerative Medicine at the Medical University of South Carolina. Dr. Hartman completed her Ph.D. with the support of a NSF GRFP fellowship at the University of Arkansas for Medical Sciences in the lab of Dr. Grover Miller studying enzyme kinetics of substrate oxidation by cytochrome P450 2E1 (CYP2E1). She then went on to do a NIEHS F32-supported postdoctoral fellowship with Dr.

Research interests: cardiovascular complications of liver disease including cirrhotic cardiomyopathy. Clinical interest: improving hepatology care for marginalized populations, especially Indigenous People.

Dr. Reem Sharaiha is an Associate Professor of Medicine at the Weill Medical College of Cornell University. She is the Chief of endoscopy as well as the director of Interventional and Therapeutic endoscopy as well as the director of bariatric and metabolic endoscopy. She is a pioneer in the field and an expert advanced endoscopist in pancreaticobiliary disease and in endoscopic (non surgical) treatment for weight loss and the improvement of weight-related health conditions.

Dr. Brittany Bromfield earned her medical degree from the University of the West Indies in Jamaica and completed her internal medicine residency at the University of Pittsburgh Medical Education Program. She is currently a gastroenterology and hepatology fellow at Brigham and Women's Hospital. Her clinical and research interests include alcohol-related liver disease (ALD), MetALD, MASLD, and obesity, with a focus on the intersection of metabolic dysfunction and addiction.

Dr. Liangpunsakul is a Professor of Medicine, Biochemistry, and Molecular Biology in the Division of Gastroenterology and Hepatology at Indiana University. His research focuses on basic, translational, and clinical studies to determine the pathogenesis of alcohol-associated liver disease (ALD). He is the principal investigator of research projects funded by the US Department of Veterans Affairs (Merit Review) as well as the National Institutes of Health (NIH/NIAAA). He has authored or co-authored more than 250 peer-reviewed articles.